About Lilly
Lilly is a company based in United States founded in 1876 by Eli Lilly. The company has 47,000 employees as of December 31, 2024. Lilly has completed 38 acquisitions, including 4E Therapeutics, Adverum Biotechnologies and Ajax Therapeutics. Lilly operates in a competitive market with competitors including Merck, Roivant Sciences, AbbVie, Gilead and Vertex Pharmaceuticals, among others.
- Headquarter United States
- Employees 47000 as on 31 Dec, 2024
- Founders Eli Lilly
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Eli Lilly And Company
-
Annual Revenue
$45.04 B (USD)32as on Dec 31, 2024
-
Net Profit
$10.59 B (USD)102.08as on Dec 31, 2024
-
EBITDA
$18.81 B (USD)58.67as on Dec 31, 2024
-
Latest Funding Round
Not available
-
Investors
Moody's
& 4 more
-
Employee Count
47000
as on Dec 31, 2024
-
Investments & Acquisitions
4E Therapeutics
& 37 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Lilly
Lilly is a publicly listed company on the NYSE with ticker symbol LLY in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
People of Lilly
Unlock access to complete
Unlock access to complete
Leadership Team
53 people
Software Development Team
41 people
Legal and Compliance
20 people
Product Management Team
14 people
Board Team
8 people
Sales and Marketing
7 people
Human Resources and Administration
6 people
Senior Team
6 people
Unlock access to complete
Funding Insights of Lilly
Investors in Lilly
Lilly has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include Moody's, Gates Foundation and HHS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Charitable foundation investments on poverty reduction and healthcare
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Financial databases for credit ratings and analytics are maintained.
|
Locked | Locked | Locked |
Investor details for Lilly
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lilly
Lilly has strategically engaged in corporate development activities, having acquired 38 companies. Notable acquisitions include 4E Therapeutics, Adverum Biotechnologies and Ajax Therapeutics.
Investment portfolio details for Lilly
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Antibody-Drug Conjugate therapeutics are developed using stable dual-linker technology.
|
Locked | Locked | 2023 | Locked | |
|
Medicines for sleep-wake, neurological, neurodegenerative, and psychiatric disorders are developed.
|
Locked | Locked | 2021 | Locked | |
|
Developer of immunotherapies for the treatment of cancer
|
Locked | Locked | 2021 | Locked |
Complete acquisition details for Lilly
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Lilly
Detailed financials for Lilly
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Lilly Comparisons
Peer comparison for Lilly
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Lilly
Lilly operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Merck, Roivant Sciences, AbbVie, Gilead and Vertex Pharmaceuticals, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Pharmaceutical products are manufactured and marketed worldwide.
|
|
| Locked | Locked | Locked |
Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed.
|
|
| Locked | Locked | Locked |
Biopharmaceutical research and drug development are conducted globally by AbbVie.
|
|
| Locked | Locked | Locked |
Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others
|
|
| Locked | Locked | Locked |
Developer of drugs for the treatment of multiple disorders
|
Detailed competitors of Lilly
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Lilly
Complete news archive for Lilly
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Lilly
Lilly was founded in 1876 and raised its 1st funding round 131 years after it was founded.
Lilly is headquartered in United States.
As of Dec 31, 2024, the latest employee count at Lilly is 47,000.
Annual revenue of Lilly is $45.04B as on Dec 31, 2024.
The company was founded in 1876 in the United States by Eli Lilly and operates within the pharmaceutical sector. Traditional medicines are developed and produced across oncology, cardiovascular, diabetes, critical care, neuroscience, mens health, and musculoskeletal areas. In 2022, annual revenues of 28.54 billion were recorded, alongside a net profit of 6.24 billion. Focus remains on established drug development processes.
Lilly's top competitors include Merck, Roivant Sciences and AbbVie.
Yes, Lilly is publicly traded on NYSE under the ticker symbol LLY.
Lilly has made 38 acquisitions, including 4E Therapeutics, Adverum Biotechnologies, and Ajax Therapeutics.
Lilly has 5 investors. Key investors include Moody's, Gates Foundation, HHS, European Union, and United States Geological Survey.
The ticker symbol of Lilly is LLY on NYSE.